Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer

about

Treatments for Metastatic Prostate Cancer (mPC): A Review of Costing Evidence.Impact of subsequent metastases on costs and medical resource use for prostate cancer patients initially diagnosed with localized disease.

P2860

Q38653262-62376C6F-A19E-494B-84D2-913DF8339E3A Q38764787-97803D2B-9F6D-4855-B52D-50F47E56EED3

P2860

Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer

Item

http://www.wikidata.org/entity/Q36263586

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer

@ast

Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer

@en

type

Item

label

Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer

@ast

Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer

@en

prefLabel

Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer

@ast

Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer

@en

P1476

Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer

@en

P2093

Michaela A Dinan

http://www.w3.org/2001/XMLSchema#string

Shelby D Reed

http://www.w3.org/2001/XMLSchema#string

Timothy J Robinson

http://www.w3.org/2001/XMLSchema#string

W Robert Lee

http://www.w3.org/2001/XMLSchema#string

Yanhong Li

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases - an evidence-based practice guideline

The utility of Medicare claims data for measuring cancer stage.

Development of a comorbidity index using physician claims data.

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Utility of the SEER-Medicare data to identify chemotherapy use.

Estimating health care costs related to cancer treatment from SEER-Medicare data.

Utility of administrative claims data for the study of brain metastases: a validation study.

Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.

Identification of metastatic cancer in claims data.

Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007

P304

933-939

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/JPM.2015.0171

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26241733

http://www.w3.org/2001/XMLSchema#string

P932

4638209

http://www.w3.org/2001/XMLSchema#string

Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer

about

P2860

P2860

Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932